What is the risk of intensifying platelet inhibition beyond clopidogrel? A systematic review and a critical appraisal of the role of prasugrel.

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Testa, L, Bhindi, R, Van Gaal, W, Latini, R, Pizzocri, S, Lanotte, S, Biondi Zoccai, G, Valgimigli, M, Laudisa, M, Brambilla, N, Banning, A, Bedogni, F
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2010

Drug eluting stents versus bare metal stents in the treatment of saphenous vein graft disease: a systematic review and meta-analysis.
de réir: Testa, L, et al.
Foilsithe / Cruthaithe: (2010)

Current Concepts on Antiplatelet Therapy: Focus on the Novel Thienopyridine and Non-Thienopyridine Agents
de réir: L. Testa, et al.
Foilsithe / Cruthaithe: (2010-01-01)

Use of prasugrel in patients with clopidogrel hypersensitivity
de réir: Aparna Joshi, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Interaction between statins and clopidogrel: is there anything clinically relevant?
de réir: Bhindi, R, et al.
Foilsithe / Cruthaithe: (2008)

Differential impact of diabetes mellitus on antiplatelet effects of prasugrel and clopidogrel
de réir: Satoshi Niijima, et al.
Foilsithe / Cruthaithe: (2018-03-01)

Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition.
de réir: Testa, L, et al.
Foilsithe / Cruthaithe: (2009)

Low-Dose Prasugrel in Patients with Resistance to Clopidogrel for the Treatment of Cerebral Aneurysms
de réir: Dongwhane Lee, et al.
Foilsithe / Cruthaithe: (2018-09-01)

Clinical utility of remote platelet function measurement using P-selectin: assessment of aspirin, clopidogrel, and prasugrel and bleeding disorders
de réir: Philip M Bath, et al.
Foilsithe / Cruthaithe: (2018-07-01)

Platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor in comparison to clopidogrel: a retrospective pharmacodynamic analysis
de réir: Gerhard Selhorst, et al.
Foilsithe / Cruthaithe: (2019-04-01)

Repeat thrombolysis or conservative therapy vs. rescue percutaneous coronary intervention for failed thrombolysis: systematic review and meta-analysis.
de réir: Testa, L, et al.
Foilsithe / Cruthaithe: (2008)

Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases
de réir: Jan Kiebist, et al.
Foilsithe / Cruthaithe: (2021-09-01)

Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
de réir: Jim McLenachan, et al.
Foilsithe / Cruthaithe: (2019-05-01)

In silico Investigation on Clopidogrel, Prasugrel and Ticagrelor as Potential Mono Antiplatelet Therapy for Acute Coronary Syndrome
de réir: Muhammad Naufal Hibatullah, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Effect of CYP2C19 status on platelet reactivity in Taiwanese acute coronary syndrome patients switching to prasugrel from clopidogrel: Switch Study
de réir: Feng-Yu Kuo, et al.
Foilsithe / Cruthaithe: (2022-09-01)

Prasugrel
de réir: Gianluca Airoldi, et al.
Foilsithe / Cruthaithe: (2013-04-01)

Correction: Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
Foilsithe / Cruthaithe: (2019-07-01)

Stent Thrombosis Patients with Hyporesponsiveness to Clopidogrel, Prasugrel, and Ticagrelor: A Case Series Using Short Thromboelastography
de réir: Bartosz Olechowski, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Impact of immature platelet fraction on platelet reactivity during prasugrel maintenance treatment
de réir: Monica Verdoia, et al.
Foilsithe / Cruthaithe: (2019-10-01)

Low-dose Prasugrel in Patients with Resistance to Clopidogrel for the Treatment of Cerebral Aneurysms: Follow-up of over 6 Months
de réir: Dongwhane Lee, et al.
Foilsithe / Cruthaithe: (2019-03-01)

Pexelizumab in ischemic heart disease: a systematic review and meta-analysis on 15,196 patients.
de réir: Testa, L, et al.
Foilsithe / Cruthaithe: (2008)

Clopidogrel, ticagrelor, prasugrel or an alternation of two P2Y12 in patients with acute myocardial infarction with cardiogenic shock
de réir: Vojko Kanic, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Long-term use of clopidogrel versus ticagrelor or prasugrel in patients with acute myocardial infarction after percutaneous coronary intervention
de réir: Yuri Kim, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Long-term use of clopidogrel versus ticagrelor or prasugrel in patients with acute myocardial infarction after percutaneous coronary intervention.
de réir: Yuri Kim, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Time Course of Ischemic and Bleeding Burden in Elderly Patients With Acute Coronary Syndromes Randomized to Low‐Dose Prasugrel or Clopidogrel
de réir: Gabriele Crimi, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Gradual increase in thrombogenicity of juvenile platelets formed upon offset of prasugrel medication
de réir: Constance C. F. M. J. Baaten, et al.
Foilsithe / Cruthaithe: (2015-09-01)

Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native artery.
de réir: Testa, L, et al.
Foilsithe / Cruthaithe: (2009)

Prasugrel Results in Higher Decrease in High-Sensitivity C-Reactive Protein Level in Patients Undergoing Percutaneous Coronary Intervention Comparing to Clopidogrel
de réir: Shokoufeh Hajsadeghi, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Prasugrel Results in Higher Decrease in High-Sensitivity C-Reactive Protein Level in Patients Undergoing Percutaneous Coronary Intervention Comparing to Clopidogrel
de réir: Shokoufeh Hajsadeghi, et al.
Foilsithe / Cruthaithe: (2016-08-01)

The effect of doubling the dose of clopidogrel on platelet aggregation in patients with clopidogrel resistance
de réir: John I. Louca, et al.
Foilsithe / Cruthaithe: (2014-09-01)

NICHE OF PRASUGREL AMONG OTHER PLATELET P2Y12-RECEPTOR INHIBITORS
de réir: P. S. LAGUTA, et al.
Foilsithe / Cruthaithe: (2017-12-01)

Legacy of blood: does prasugrel inhibit megakaryocytes and do juvenile platelets inherit this inhibition?
de réir: Carlos G. Santos-Gallego
Foilsithe / Cruthaithe: (2015-09-01)

Impact of Prasugrel and Ticagrelor on Platelet Reactivity in Patients With Acute Coronary Syndrome: A Meta-Analysis
de réir: Lulu Dai, et al.
Foilsithe / Cruthaithe: (2022-06-01)

The hurdles of translating a single-center observation into practice.
de réir: Testa, L, et al.
Foilsithe / Cruthaithe: (2008)

Digitalis: a dangerous drug in atrial fibrillation?
de réir: Testa, L, et al.
Foilsithe / Cruthaithe: (2008)

Mortality in primary angioplasty patients starting antiplatelet therapy with prehospital prasugrel or clopidogrel: a 1-year follow-up from the European MULTIPRAC Registry
de réir: Goldstein P, et al.
Foilsithe / Cruthaithe: (2016-04-01)

Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
de réir: Zhe Wang, et al.
Foilsithe / Cruthaithe: (2020-03-01)

The effect of concurrent clopidogrel and omeprazole administration on clopidogrel metabolism and platelet function in healthy cats
de réir: Christina Plante, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Sepsis favors high-on-clopidogrel platelet reactivity
de réir: Karolina Akinosoglou, et al.
Foilsithe / Cruthaithe: (2018-01-01)

Platelet Reactivity and Response to Aspirin and Clopidogrel in Patients with Platelet Count Disorders
de réir: Wiktor Kuliczkowski, et al.
Foilsithe / Cruthaithe: (2021-01-01)

PRASUGREL: FREQUENTLY ASKED QUESTIONS FROM PRACTITIONERS
de réir: O. O. Shakhmatova, et al.
Foilsithe / Cruthaithe: (2019-06-01)

What is the risk of intensifying platelet inhibition beyond clopidogrel? A systematic review and a critical appraisal of the role of prasugrel.

Míreanna comhchosúla

Míreanna comhchosúla